Showing 2331-2340 of 2894 results for "".
- ASLMS 2025: New Laser Platforms Expand Options for Vascular Rosaceahttps://modernaesthetics.com/news/aslms-2025-new-laser-platforms-expand-options-for-vascular-rosacea/2475358/Advanced vascular lasers are transforming the treatment of rosacea by targeting its root cause (chronic vascular dilation) rather than just managing inflammation. At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, Eric Bernstein, MD, Director of
- Tattoo Removal Trends Revealed in Global Analysis of Over 200,000 Individualshttps://modernaesthetics.com/news/tattoo-removal-trends-revealed-in-global-analysis-of-over-200000-individuals/2475357/Key Takeaways Individuals aged 18–39 make up two-thirds of those seeking tattoo removal, with visible areas such as forearms and hands being the most treated. Black ink remains the most commonly removed tattoo pigment. Fitzpatrick Skin Types III and
- Bausch Health Launches Fraxel FTX™ at ASLMS 2025https://modernaesthetics.com/news/bausch-health-launches-fraxel-ftx-at-aslms-2025/2475353/Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a natio
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum toxin
- Research Firm Executive Explains Optimistic Market Forecasthttps://modernaesthetics.com/news/research-firm-executive-explains-optimistic-market-forecast/2475344/The research firm Clarivate projected the global aesthetics market to reach a value of €22.9 billion by 2028, growing at a compound annual growth rate (CAGR) of nearly 8%. This growth, Clarivate said, is driven by trends such as the shift toward natural-looking treatments, the rise of combination
- Actress Shay Mitchell to Serve as Global Brand Ambassador for OGXhttps://modernaesthetics.com/news/actress-shay-mitchell-to-serve-as-global-brand-ambassador-for-ogx/2475343/Kenvue Inc. introduced actress and entrepreneur Shay Mitchell as the global brand ambassador for OGX®, stepping in as the face of the brand’s Fixer character in their new campaign. "My life is busy, and my hair goes through a lot," Mitchell said in a press release. "OGX products keep my ha
- Advalight to Directly Manage Its Sales Operations, Introduce New Laserhttps://modernaesthetics.com/news/advalight-to-directly-manage-its-sales-operations-introduce-new-laser/2475342/Danish laser company Advalight will directly manage its sales operations moving forward, the president of the company’s US subsidiary said on LinkedIn. Travis Mahan, president of Advalight Corp and executive vice president of global sales for Advalight, said the move is “to better align wi
- The Aesthetic Foundation Appoints Dr. Patricia A. McGuire New Presidenthttps://modernaesthetics.com/news/the-aesthetic-foundation-appoints-dr-patricia-a-mcguire-new-president/2475340/The Aesthetic Foundation recently announced the appointment of Patricia A. McGuire, MD, as its new president. Dr. McGuire is a board-certified plastic surgeon and breast surgery specialist. The Aesthetic Foundation said in a press release she brings “decades of experience in patient-cente
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://modernaesthetics.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- 2025 AAD: Drs. Shino Bay Aguilera, Michael Somenek Face Off Over Filler Treatmentshttps://modernaesthetics.com/news/2025-aad-drs-shino-bay-aguilera-michael-somenek-face-off-over-filler-treatments/2473759/A ticketed session at the 2025 American Academy of Dermatology (AAD) Annual Meeting brought together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural